These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15251887

  • 1. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE, Bruijnzeel AW, Ghozland S, Markou A, Koob GF.
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K, Vouillac C, Koob GF, Cador M, Stinus L.
    Biol Psychiatry; 2008 Jan 15; 63(2):158-63. PubMed ID: 17643399
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y, Jutkiewicz EM, Zhang A, Domino EF.
    Pharmacol Biochem Behav; 2011 Oct 15; 99(4):552-6. PubMed ID: 21624384
    [Abstract] [Full Text] [Related]

  • 4. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Panagis G, Hildebrand BE, Svensson TH, Nomikos GG.
    Synapse; 2000 Jan 15; 35(1):15-25. PubMed ID: 10579804
    [Abstract] [Full Text] [Related]

  • 5. Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
    Jain R, Mukherjee K, Mohan D.
    Pharmacol Biochem Behav; 2008 Feb 15; 88(4):473-80. PubMed ID: 18031800
    [Abstract] [Full Text] [Related]

  • 6. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
    Damaj MI, Kao W, Martin BR.
    J Pharmacol Exp Ther; 2003 Nov 15; 307(2):526-34. PubMed ID: 12970387
    [Abstract] [Full Text] [Related]

  • 7. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S, Markou A.
    Neurosci Lett; 2006 May 29; 400(1-2):140-5. PubMed ID: 16563623
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
    Jackson A, Papke RL, Damaj MI.
    Psychopharmacology (Berl); 2018 Jul 29; 235(7):1897-1905. PubMed ID: 29549391
    [Abstract] [Full Text] [Related]

  • 9. Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats.
    O'Dell LE, Chen SA, Smith RT, Specio SE, Balster RL, Paterson NE, Markou A, Zorrilla EP, Koob GF.
    J Pharmacol Exp Ther; 2007 Jan 29; 320(1):180-93. PubMed ID: 17050784
    [Abstract] [Full Text] [Related]

  • 10. A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration.
    Slotkin TA, Seidler FJ.
    Neurotoxicol Teratol; 2007 Jan 29; 29(1):10-6. PubMed ID: 16919421
    [Abstract] [Full Text] [Related]

  • 11. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
    Harris AC, Manbeck KE, Schmidt CE, Shelley D.
    Psychopharmacology (Berl); 2013 Jan 29; 225(2):291-302. PubMed ID: 22868410
    [Abstract] [Full Text] [Related]

  • 12. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE, Markou A.
    Psychopharmacology (Berl); 2004 Apr 29; 173(1-2):64-72. PubMed ID: 14712336
    [Abstract] [Full Text] [Related]

  • 13. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
    Malin DH, Lake JR, Carter VA, Cunningham JS, Hebert KM, Conrad DL, Wilson OB.
    Psychopharmacology (Berl); 1994 Jun 29; 115(1-2):180-4. PubMed ID: 7862893
    [Abstract] [Full Text] [Related]

  • 14. Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.
    Kwilasz AJ, Harris LS, Vann RE.
    Pharmacol Biochem Behav; 2009 Nov 29; 94(1):114-8. PubMed ID: 19660491
    [Abstract] [Full Text] [Related]

  • 15. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
    Shram MJ, Siu EC, Li Z, Tyndale RF, Lê AD.
    Psychopharmacology (Berl); 2008 Jun 29; 198(2):181-90. PubMed ID: 18385986
    [Abstract] [Full Text] [Related]

  • 16. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
    Malin DH, Moon WD, Goyarzu P, Magallanes N, Blair MB, Alexander MR, McDavid L, Spurgeon JL, Ennifar S, Fattom A.
    Nicotine Tob Res; 2010 Apr 29; 12(4):438-44. PubMed ID: 20203107
    [Abstract] [Full Text] [Related]

  • 17. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS, Stinus L, Koob GF, Markou A.
    J Pharmacol Exp Ther; 2000 Mar 29; 292(3):1053-64. PubMed ID: 10688623
    [Abstract] [Full Text] [Related]

  • 18. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Rose JE, Behm FM, Ramsey C, Ritchie JC.
    Nicotine Tob Res; 2001 Nov 29; 3(4):383-90. PubMed ID: 11694206
    [Abstract] [Full Text] [Related]

  • 19. Behavioral effects of nicotine withdrawal in adult male and female rats.
    Hamilton KR, Berger SS, Perry ME, Grunberg NE.
    Pharmacol Biochem Behav; 2009 Mar 29; 92(1):51-9. PubMed ID: 19000707
    [Abstract] [Full Text] [Related]

  • 20. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Wing VC, Shoaib M.
    Psychopharmacology (Berl); 2007 Dec 29; 195(3):303-13. PubMed ID: 17690868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.